{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:03:28Z","timestamp":1779102208448,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2018GCF118137"],"award-info":[{"award-number":["2018GCF118137"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00253-023-12851-3","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T13:02:17Z","timestamp":1704286937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Construction of rBCG carrying the IL-2-BZLF1 fusion gene and its immunological function"],"prefix":"10.1007","volume":"108","author":[{"given":"Meimei","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5561-4091","authenticated-orcid":false,"given":"Qingjie","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huabao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"12851_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-3-319-64371-7_8","volume":"1019","author":"AM Abdallah","year":"2017","unstructured":"Abdallah AM, Behr MA (2017) Evolution and strain variation in BCG. Adv Exp Med Biol 1019:155\u2013169. https:\/\/doi.org\/10.1007\/978-3-319-64371-7_8","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"12851_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/nar\/gkab1183","volume":"50","author":"F Bernaudat","year":"2022","unstructured":"Bernaudat F, Gustems M, G\u00fcnther J, Oliva MF, Buschle A, G\u00f6bel C, Pagniez P, Lupo J, Signor L, M\u00fcller CW, Morand P, Sattler M, Hammerschmidt W, Petosa C (2022) Structural basis of DNA methylation-dependent site selectivity of the Epstein-Barr virus lytic switch protein ZEBRA\/Zta\/BZLF1. Nucleic Acids Res 50(1):490\u2013511. https:\/\/doi.org\/10.1093\/nar\/gkab1183","journal-title":"Nucleic Acids Res"},{"key":"12851_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/ijc.20594","volume":"113","author":"F Chen","year":"2005","unstructured":"Chen F, Liu C, Lindvall C, Xu D, Ernberg (2005) Epstein-Barr virus latent membrane ZA(LMP2A)down reg\u03bclates telomerase reverse transeriptase(hTERT) in epithelial cell lines. Int J Caneer 113:284\u2013289. https:\/\/doi.org\/10.1002\/ijc.20594","journal-title":"Int J Caneer"},{"key":"12851_CR4","doi-asserted-by":"publisher","first-page":"734471","DOI":"10.3389\/fimmu.2021.734471","volume":"12","author":"X Cui","year":"2021","unstructured":"Cui X, Snapper CM (2021) Epstein Barr virus: Development of vaccines and immune cell therapy for EBV-associated diseases. Front Immunol 12:734471. https:\/\/doi.org\/10.3389\/fimmu.2021.734471","journal-title":"Front Immunol"},{"issue":"7","key":"12851_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1158\/2326-6066.CIR-14-0242","volume":"3","author":"AS Hartlage","year":"2015","unstructured":"Hartlage AS, Liu T, Patton JT, Garman SL, Zhang XL, Kurt H, Lozanski G, Lustberg ME, Caligiuri MA, Baiocchi RA (2015) The Epstein-Barr virus lytic protein BZLF1 as a candidate target antigen for vaccine development. Cancer Immunol Res 3(7):787\u2013794. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0242","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"12851_CR6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/cas.13954","volume":"110","author":"T Kanda","year":"2019","unstructured":"Kanda T, Yajima M, Ikuta K (2019) Epstein-Barr virus strain variation and cancer. Cancer Sci 110(4):1132\u20131139. https:\/\/doi.org\/10.1111\/cas.13954","journal-title":"Cancer Sci"},{"issue":"10","key":"12851_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jclinpath-2019-205822","volume":"72","author":"JR Kerr","year":"2019","unstructured":"Kerr JR (2019) Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol 72(10):651\u2013658. https:\/\/doi.org\/10.1136\/jclinpath-2019-205822","journal-title":"J Clin Pathol"},{"issue":"8","key":"12851_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1080\/14760584.2021.1951243","volume":"20","author":"LM Marques-Neto","year":"2021","unstructured":"Marques-Neto LM, Piwowarska Z, Kanno AI, Moraes L, Trentini MM, Rodriguez D, Silva JLSC, Leite LCC (2021) Thirty years of recombinant BCG: new trends for a centenary vaccine. Expert Rev Vaccines 20(8):1001\u20131011. https:\/\/doi.org\/10.1080\/14760584.2021.1951243","journal-title":"Expert Rev Vaccines"},{"key":"12851_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clim.2018.11.002","volume":"206","author":"M Mizui","year":"2019","unstructured":"Mizui M (2019) Natural and modified IL-2 for the treatment of cancer and autoimmune diseases. Clin Immunol 206:63\u201370. https:\/\/doi.org\/10.1016\/j.clim.2018.11.002","journal-title":"Clin Immunol"},{"issue":"9","key":"12851_CR10","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3390\/cells9092063","volume":"9","author":"VK Raker","year":"2020","unstructured":"Raker VK, Becker C, Landfester K, Steinbrink K (2020) Targeted activation of T cells with IL-2-coupled nanoparticles. Cells 9(9):2063. https:\/\/doi.org\/10.3390\/cells9092063","journal-title":"Cells"},{"issue":"1","key":"12851_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1128\/JVI.02642-14","volume":"89","author":"MJ Rist","year":"2015","unstructured":"Rist MJ, Neller MA, Burrows JM, Burrows SR (2015) T-cell epitope clustering in the highly immunogenic BZLF1 antigen of Epstein-Barr virus. J Virol 89(1):703\u2013712. https:\/\/doi.org\/10.1128\/JVI.02642-14","journal-title":"J Virol"},{"key":"12851_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fimmu.2018.00444","volume":"9","author":"BL Salomon","year":"2018","unstructured":"Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E, Cohen JL (2018) Tumor necrosis factor \u03b1 and regulatory T cells in oncoimmunology. Front Immunol 9:444. https:\/\/doi.org\/10.3389\/fimmu.2018.00444","journal-title":"Front Immunol"},{"issue":"3","key":"12851_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","volume":"19","author":"N Shimasaki","year":"2020","unstructured":"Shimasaki N, Jain A, Campana D (2020) NK cells for cancer immunotherapy. Nat Rev Drug Discov 19(3):200\u2013218. https:\/\/doi.org\/10.1038\/s41573-019-0052-1","journal-title":"Nat Rev Drug Discov"},{"issue":"6326","key":"12851_CR14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/351456a0","volume":"351","author":"CK Stover","year":"1991","unstructured":"Stover CK, Dela Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF, Snapper SB, Barletta RG, Jacobs WR Jr, Bloom BR (1991) New use of BCG for recombinant vaccines. Nature 351(6326):456\u2013460. https:\/\/doi.org\/10.1038\/351456a0","journal-title":"Nature"},{"key":"12851_CR15","doi-asserted-by":"publisher","unstructured":"Treuer R, Haydel SE (2011)Acid-fast staining and petroff hausser chamber counting of mycobacterial cells in liquid suspension. Curr Protoc Microbiol: 1\u20138. https:\/\/doi.org\/10.1002\/9780471729259.mc10a06s20","DOI":"10.1002\/9780471729259.mc10a06s20"},{"issue":"1","key":"12851_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00253-021-11682-4","volume":"106","author":"QJ Xue","year":"2022","unstructured":"Xue QJ, Yu HX, Liu A, Wang H, Chen T, Li YQ, Chen T, Wang QL (2022) The inhibitory effect of rBCG on EB virus-positive tumors using an EB virus fusion gene. Appl Microbiol Biotechnol 106(1):185\u2013195. https:\/\/doi.org\/10.1007\/s00253-021-11682-4","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"12851_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/21645515.2019.1670593","volume":"16","author":"YC Yan","year":"2020","unstructured":"Yan YC, Xue QJ, Liu A, Li XZ, Yang YY, Chen T, Li SG (2020) EB virus-positive tumors are inhibited by rBCG expressing hGM-CSF and LMP2A. Hum Vaccin Immunother 16(3):654\u2013663. https:\/\/doi.org\/10.1080\/21645515.2019.1670593","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"12851_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00430-018-0570-1","volume":"208","author":"H Yin","year":"2019","unstructured":"Yin H, Qu J, Peng Q, Gan R (2019) Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis. Med Microbiol Immunol 208(5):573\u2013583. https:\/\/doi.org\/10.1007\/s00430-018-0570-1","journal-title":"Med Microbiol Immunol"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-023-12851-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-023-12851-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-023-12851-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:41:13Z","timestamp":1748378473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-023-12851-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["12851"],"URL":"https:\/\/doi.org\/10.1007\/s00253-023-12851-3","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"12 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving mice were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All animal experiments were approved by the Shandong animal experimentation committees (2009\u20130023; approval date, 2\/25\/09\u20133\/25\/14).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"19"}}